MedPage Today brought together three expert leaders for a virtual roundtable discussion on pediatric low-grade glioma. Moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, ...
These tumors are less likely to spread to surrounding tissues than higher-grade tumors, so they often have better outcomes. In the past, pediatric gliomas were classified into low-grade and high-grade ...
The genes encoding IDH1/2 and BRAF are frequently altered in low-grade glioma; the presence or absence of these alterations should be determined in all patients. Maximal safe tumor resection remains ...
At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a global phase III trial showing that the targeted therapy vorasidenib more than doubled progression-free ...
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered ...
Investigators explored the utility of unplanned resections, also called reresection, among patients who have soft tissue sarcomas. Experts have issued caution when considering reresection among ...
Among patients with stage III melanoma who received adjuvant pembrolizumab, more than 50% experienced low-grade toxicities. The results of such toxicities included patients discontinuing treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results